
Hybrid Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100359 - 100359
Published: Dec. 1, 2024
Language: Английский
Hybrid Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100359 - 100359
Published: Dec. 1, 2024
Language: Английский
Journal of Functional Biomaterials, Journal Year: 2024, Volume and Issue: 15(8), P. 225 - 225
Published: Aug. 14, 2024
The intersection of immunology and nanotechnology has provided significant advancements in biomedical research clinical applications over the years. Immunology aims to understand immune system’s defense mechanisms against pathogens. Nanotechnology demonstrated its potential manipulate responses, as nanomaterials’ properties can be modified for desired application. Research shown that nanomaterials applied diagnostics, therapy, vaccine development. In used biosensor development, accurately detecting biomarkers even at very low concentrations. Therapeutically, act efficient carriers delivering drugs, antigens, or genetic material directly targeted cells tissues. This delivery improves therapeutic efficacy reduces adverse effects on healthy nanoparticles improve durability extend responses by effectively adjuvants antigens cells. Despite these advancements, challenges regarding safety, biocompatibility, scalability are still present. review will cover fundamental interactions between system, their immunology, safety biocompatibility concerns.
Language: Английский
Citations
6Nanomedicine, Journal Year: 2024, Volume and Issue: 19(11), P. 995 - 1012
Published: April 9, 2024
Aim: To investigate the influence of fluorine in reducing adsorption immune-reactive proteins onto PEGylated gold nanoparticles. Methods: Reversible addition fragmentation chain transfer polymerization, Turkevich method and ligand exchange were used to prepare polymer-coated Subsequent vitro physicochemical biological characterizations proteomic analysis performed. Results: Fluorine-modified polymers reduced complement other while potentially improving circulatory times modulating liver toxicity by apolipoprotein E adsorption. Fluorine actively discouraged phagocytosis encouraging therapeutic targets, CD209 signaling molecule calreticulin. Conclusion: This study suggests that surface coating nanoparticles could lead improved performance nanomedicine designed for intravenous delivery cargos.
Language: Английский
Citations
5Biocatalysis and Agricultural Biotechnology, Journal Year: 2024, Volume and Issue: 58, P. 103223 - 103223
Published: May 11, 2024
Exploring secondary outputs, specifically leftover materials from steam distillation of Rosmarinus tournefortii de Noé, as agents for reducing metals introduces a novel approach to eco-friendly nanomaterial production. This concept aligns with the creation environmentally conscious nanoparticles, showcasing potential across various fields, notably biomedicine. The paper seamlessly fits into this context. By utilizing R. successful synthesis silver nanoparticles (AgNPs) was achieved, yielding nanoscale variations influenced by plant's by-products. Beyond structural aspects, investigating biomedical applications, focusing on antioxidant and antimicrobial properties. Consistently observing ∼94.9–97.3% scavenging inhibition in water residues at different concentrations enhanced efficacy against Gram-negative Gram-positive bacteria Rhodotorula glutinis yeast due these residues. Moreover, thorough examination using density functional theory unveiled robust interaction between clusters specific biomolecules found within residues, namely homoplantaginin, protocatechuic acid-glycoside, caffeic, rosmarinic acids (ranging 130.62 357.05 kcal/mol). These compounds enhance Ag+ ions contribute enduring stability AgNPs (ζ values: -22.8 mV -17.2 mV). Furthermore, study recognizes challenges finding alternative surface modification explores intricate toxicity mechanisms emphasizing their interactions inflammation. Introducing promising nanomedicine approaches involving acid inflammatory bowel disease rheumatoid arthritis, highlighting rosemary by-products derived innovative therapeutic interventions diverse conditions.
Language: Английский
Citations
5International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 666, P. 124819 - 124819
Published: Oct. 16, 2024
Language: Английский
Citations
5Hybrid Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100359 - 100359
Published: Dec. 1, 2024
Language: Английский
Citations
5